Following administration, Modified GRF(1-29) produces peak effects within 15-30 minutes, with duration of elevated GH typically lasting 2-3 hours based on GHRH analog pharmacology
According to IKDSG guidelines, KD use is strictly contraindicated in patients with a deficiency of carnitine (primary), carnitine palmitoyltransferase (CPT) 1 or 2, carnitine translocase, pyruvate carboxylase, medium-chain acyl-coenzyme A (CoA) dehydrogenase (MCAD), long-chain acyl-CoA dehydrogenase (LCAD), short-chain acyl-CoA dehydrogenase (SCAD), and disorders of fatty acid -oxidation and porphyria
3a), which is well consistent with the tendency of transcriptome data from plants in response to wounding, namely, more transcripts are upregulated than downregulated 27,28
Repeated inadvertent ingestion of supratherapeutic doses may be especially dangerous, due to subacute depletion of hepatic glutathione stores